AI becoming core infrastructure for pharmaceutical R&D, not just an experimental tool: Report

New Delhi [India], August 8 (ANI): Artificial intelligence (AI) is rapidly becoming a core part of pharmaceutical research and development (R&D), moving beyond its role as an experimental technology to help companies accelerate drug discovery, improv... [3331 chars]
Read Original

Related